Karen Lu
Impact in
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Papers in
-
- Phenothiazines and Benzothiazines Synthesis and Activities 2
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Rouba Ali‐Fehmi (1 shared paper)Sara H. Olson (1 shared paper)Julie J. Ruterbusch (1 shared paper)Michele L. Coté (1 shared paper)Richard G. Moore (1 shared paper)Zhen Lü (1 shared paper)Amy Brown (1 shared paper)Michael Craig Miller (1 shared paper)
- Journals
- Gynecologic Oncology (4 papers)Clinical Pharmacology & Therapeutics (2 papers)Cancer (1 paper)Cancer Epidemiology Biomarkers & Prevention (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Karen Lu
13 papers receiving 470 citations
Peers
Comparison fields: 5 of 52
- Obstetrics and Gynecology 251
- Reproductive Medicine 228
- Cancer Research 98
- Oncology 112
- Pathology and Forensic Medicine 57
Countries citing papers authored by Karen Lu
This map shows the geographic impact of Karen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Lu more than expected).
Fields of papers citing papers by Karen Lu
This network shows the impact of papers produced by Karen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Lu. The network helps show where Karen Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Karen Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 182 | |
| 2 | 2015 | 173 | |
| 3 | 2014 | 33 | |
| 4 | Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer. | 2009 | 31 |
| 5 | 1986 | 26 | |
| 6 | 2013 | 22 | |
| 7 | Clinical pharmacology and intracerebral tumor penetration of 4'-demethyl epipodophyllotoxin 9-(4,6-O-ethylidene-β-D-glucopyranoside) (VP-16, NSC-141540) | 1982 | 5 |
| 8 | Pharmacokinetics of caracemide (CAR, NSC-253272) in dogs | 1985 | 2 |
| 9 | Clinical pharmacology of 2,5-diaziridinyl-3,6-bis-carboethoxyamino-1,4-benzoquinone, (AZQ, NSC 182986) | 1981 | 2 |
| 10 | Effects of cimetidine on the clinical pharmacokinetics of 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone (AZQ, NSC-182986) | 1982 | 1 |
| 11 | Comparison of CSF penetration of VP-16 by intracarotid (IC) intravenous (IV) and intraventricular route (IT) in dogs | 1985 | 1 |
| 12 | 2024 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 0 | |
| 15 | 2014 | 0 |
About Karen Lu
Karen Lu is a scholar working on Molecular Biology, Oncology, Obstetrics and Gynecology, Pathology and Forensic Medicine and Reproductive Medicine, having authored 15 papers that have together received 480 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (5 papers), Genetic factors in colorectal cancer (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Cancer Treatment and Pharmacology (2 papers), Synthesis and Biological Evaluation (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Uterine Myomas and Treatments (2 papers). The work is most often cited by research in Obstetrics and Gynecology (251 citations), Reproductive Medicine (228 citations), Cancer Research (98 citations), Oncology (112 citations) and Pathology and Forensic Medicine (57 citations). Karen Lu has collaborated with scholars based in United States and Canada. Frequent co-authors include Rouba Ali‐Fehmi, Sara H. Olson, Julie J. Ruterbusch, Michele L. Coté, Richard G. Moore, Zhen Lü, Amy Brown, Michael Craig Miller, W. Jeffrey Allard and Donna Badgwell. Their work appears in journals such as Gynecologic Oncology, Clinical Pharmacology & Therapeutics, Cancer, Cancer Epidemiology Biomarkers & Prevention and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.